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1. The nerve endings of rat neurohypophyses were acutely dissociated and a combination of
pharmacological, biophysical and biochemical techniques was used to determine which classes
of Ca2+ channels on these central nervous system (CNS) terminals contribute functionally to
arginine vasopressin (AVP) and oxytocin (OT) secretion.
2. Purified neurohypophysial plasma membranes not only had a single high-affinity binding
site for the N-channel-specific w-conopeptide MVIIA, but also a distinct high-affinity site for
another w-conopeptide (MVIIC), which affects both N- and P/Q-channels.
3. Neurohypophysial terminals exhibited, besides L- and N-type currents, another component
of the Ca2+ current that was only blocked by low concentrations of MVIIC or by high
concentrations of wo-AgaIVA, a P/Q-channel-selective spider toxin.
4. This Ca2+ current component had pharmacological and biophysical properties similar to those
described for the fast-inactivating form of the P/Q-channel class, suggesting that in the
neurohypophysial terminals this current is mediated by a 'Q'-type channel.
5. Pharmacological additivity studies showed that this Q-component contributed to rises in
intraterminal Ca2+ concentration ([Ca2+]i) in only half of the terminals tested.
6. Furthermore, the non-L- and non-N-component of Ca2+-dependent AVP release, but not OT
release, was effectively abolished by the same blockers of Q-type current.
7. Thus Q-channels are present on a subset of the neurohypophysial terminals where, in
combination with N- and L-channels, they control AVP but not OT peptide neurosecretion.
The regulated release of bioactive compounds from neurons
is controlled by Ca+, and an understanding of chemical
signalling by neurons thus requires an analysis of how the
various types of Ca2P channels interact to control synaptic
transmission and neurosecretion (for review, see Dunlap,
Luebke & Turner, 1995).
Voltage-dependent Ca2+ channels are involved in neuro-
transmitter release, but the existence and specific role at
central nervous system (CNS) terminals of many of the
different types of Ca2+ channels is unclear. A number of
studies have defined several electrophysiologically distinct
voltage-activated Ca2+ channels on neuronal cell bodies (for
reviews, see Bean, 1989; Tsien, Ellinor & Horne, 1991;
Llina's, Sugimori, Hillman & Cherksey, 1992). The L-, N-,
T- and P-type channels are the best characterized (Fox,
Nowycky & Tsien, 1987; Tsien et al. 1991; Llinas et at.
1992), but other classes of channels, such as the Q- and R-
types, have been revealed by molecular cloning (Snutch &
Reiner, 1992; Ellinor et al. 1993; Sather, Tanabe, Zhang,
Mori, Adams & Tsien, 1993) and the use of polypeptide
Ca2+ channel antagonists (Olivera, McIntosh, Cruz, Luque &
Grey, 1984; Hillyard et al. 1992; Ramachandran et al. 1993).
The N-type Ca2+ channel is involved in the release of
many 'classical' neurotransmitters, while the L-type is
known to regulate the secretion of certain peptides
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(Cazalis, Dayanithi & Nordmann, 1987; Dunlap et al. 1995).
The class A (alA) Ca2+ channel has recently been localized at
central nerve terminals by both immunohistochemical
studies (Westenbroek et al. 1995) and pharmacological
studies of transmitter release (Miljanich & Ramachandran,
1995). However, the phenotype of the expressed class A
channel can resemble that of native channels described as
either P or Q (Llinas et al. 1992; Sather et al. 1993; Stea et
al. 1994; Randall & Tsien, 1995), and the biophysical
properties of the class A channel in CNS terminals remain
to be determined.
In order to determine which Ca2+ channels are functionally
involved in peptide secretion, we studied the identified
nerve terminals of the rat neurohypophysis, a population of
relatively homogeneous peptidergic nerve endings that allow
comparative study by a number of different techniques. This
has been a very useful model system for identification and
characterization of nerve terminal Ca2+ channels (Lemos &
Nowycky, 1989; Wang, Treistman & Lemos, 1992; Wang &
Lemos, 1994; Fisher & Bourque, 1995) and for examination
of the mechanisms underlying depolarization-secretion
coupling (Cazalis et al. 1987; Lim, Nowycky & Bookman,
1990; Lindau, Stuenkel & Nordmann, 1992; Wang,
Treistman, Wilson, Nordmann & Lemos, 1993b). At these
terminals, certain dihydropyridines (DHP) can block a long-
lasting ('L') Ca2+ channel (Wang, Treistman & Lemos,
1993a) and a substantial portion of depolarization-
stimulated peptide release (Cazalis et al. 1987). Furthermore,
omega (w)-conopeptide GVIA at low concentrations can
block a large proportion of the transient component ('NT') of
the Ca2+ current (Wang et al. 1992) and of stimulated
peptide release (Dayanithi et al. 1988). Nonetheless, neither
channel antagonist, even when added together at saturating
concentrations, can block all of the terminal Ca2+ current or
all of the Ca2+-dependent neuropeptide release (Wang et al.
1993b). This led us to examine, using a combination of
pharmacological, biophysical and biochemical techniques,
whether another class of Ca2+ channels might also co-exist on
these CNS terminals and functionally contribute to neuro-
secretion. Part of this work has appeared previously in
abstract form (Nordmann, Dayanithi, Stuenkel, Kristipati,
Lemos & Newcomb, 1994; Wang, Newcomb, Hom, Mezo,
Ramachandran & Lemos, 1994).
METHODS
Channel blocking peptides
The &i-conopeptides used in this study were the synthetic versions,
prepared at Neurex Corp. (Ramachandran et al. 1993). These were
termed SNX-111, the synthetic version of w-conopeptide MVIIA
(Olivera, Miljanich, Ramachandran & Adams, 1994), SNX-124, the
synthetic version of w-GVIA (Olivera et al. 1984), and SNX-230, the
synthetic version of w-MVIIC (Hillyard et al. 1992). The synthetic
version of w-AgaIVA (Mintz, Venema, Swiderek, Lee, Bean &
Adams, 1992) was purchased from Peptides Intl (Louisville, KY,
USA) or synthesized as described by Gaur et al. (1994). In the text
the synthetic peptides are referred to by their original names instead
of the Neurex terms, except occasionally following in parenthesis.
Binding studies
Plasma membranes were prepared from bovine (Arena Bros
Slaughterhouse, Hopkington, MA, USA) neurohypophyses by
differential centrifugation and Percoll gradients as described for
whole rat brain (Reinhart, Chung & Levitan, 1989). Binding
experiments were performed by filtration over polyethyleneimine-
coated glass fibre filters, as described previously (Kristipati et al.
1994), with an incubation volume of 0 5 ml. Saturation experiments
used membranes containing 1f3 ,ug protein for MVIIA, and 0-8 ,ug
protein for MVIIC. Displacement experiments used 0-8 ,g protein,
and 2-4 (with MVIIA) or 5-8 pM (with MVIIC) of the radioiodinated
conopeptide; concentrations were chosen such that the highest
affinity binding sites were predominantly occupied. Consistent with
its selectivity for N-type channels, w-conopeptide-GVIA also had
a low affinity (IC50, 480 nM) in the displacement of 125I-labelled
MVIIC. Binding studies have shown that AgaIVA binds to rat
brain membranes (Adams, Myers, Imperial & Olivera, 1993).
Displacement by AgaIVA of radiolabelled MVIIC from neuro-
hypophysial membranes was observed, with an IC50 of
approximately 300 nm (data not shown).
Electrophysiological recordings
After sedation by C02, male rats were killed by decapitation using
a guillotine. The neurohypophysis was then excised, following
previously described protocols (Cazalis et al. 1987), and homogenized
in a solution containing (mM): 270 sucrose, 10 Hepes and 0-01
K2-EGTA; pH 7. The isolated neurohypophysial nerve terminals
could be identified using an inverted microscope or by using
immunoblotting following patch-clamp recordings. Normal Locke
saline (LS; Cazalis et al. 1987) was then used to perfuse the
terminals. Before recording, the terminals (usually 5-8 ,um in
diameter) were perfused with 5 mm Ba2+ LS containing (mM): 145
NaCl, 5 KCl, 5 BaCl2, 1 MgCl2, 10 Hepes, 15 glucose; and 1 ,UM
TTX; 0-02% bovine serum albumin (BSA); pH 7-3. To obtain
'whole-terminal' perforated (Rae, Cooper, Gates & Watsky, 1991)-
patch recordings (Hamill, Marty, Neher, Sakmann & Sigworth,
1981), freshly made amphotericin B (240 jug ml-') was applied in a
pipette solution that contained (mM): 135 caesium glutamate,
10 Hepes, 5 glucose, 2 CaCl2, 1 MgCl2 and 20 TEA; pH 7-3.
It is important to note that the experiments reported here were
performed using the perforated-patch (Rae et al. 1991) recording
configuration and thus there was no problem with the run-down
that complicated former studies (Lemos & Nowycky, 1989; Wang et
al. 1992; Wang & Lemos, 1994; Fisher & Bourque, 1995). Only
perforated terminals with access resistances of 3-5 MLQ were
chosen for further recordings. The Ba2+ current (IBa), which was
activated by depolarizing from -80 to +10 mV and demonstrated
both transient and long-lasting components, could be maintained
for more than 1 h without any run-down. IBa was filtered at 3 kHz
and sampled at 10 kHz. pCLAMP (Axon Instruments) was used for
acquisition and analysis of data.
Intraterminal [Ca2+]
Fura-2 was loaded into isolated nerve terminals of the rat
neurohypophysis (see Electrophysiological recordings) that had
adhered to the glass coverslip forming the bottom of the recording
chamber by perfusion of the chamber (0 5 ml min-) for 20 min at
37 °C with normal saline containing 1 /M fura-2 AM and
consisting of (mM): 100 N-methyl-D-glucamine (NMG)-Cl, 40 NaCl,
1 MgC12, 2'2 (or 1) CaCl2, 5 KHCO3, 10 glucose and 10 Hepes;
pH 7 2. Following loading, extracellular indicator was removed and
time allowed for accumulated fura-2 AM to be cleaved by changing
the perfusing solution to the same saline without the indicator.
Monitoring of the intraterminal Ca2+ concentration ([Ca2+]1) in
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individual nerve endings (generally 5-10 /sm in diameter) was
performed, following optical masking of surrounding regions, by
dual wavelength microspectrofluorometry similar to that described
previously (Stuenkel, 1990). Alternating excitation wavelengths of
340 and 380 nm were applied and photons quantified at an
emission wavelength of 510 + 10 or 500 + 20 using a photon
counting photomultiplier-based SPEX Industries AR-CM system.
The fluorescence ratio (340 nm/380 nm) was converted to [Ca!+]i by
the use of the converting equation of Grynkiewicz, Poenie & Tsien
(1985). The constants for this converting equation were determined
using an external standard calibration and a Kd value for fura-2 of
224 nm. During experimental protocols, saline or saline containing
the appropriate antagonist or antagonist plus elevated K+ was
perfused at 1-5 ml min-' through a chamber volume of 65 el.
Antagonists were generally applied for 2-4 min prior to application
of the antagonist plus elevated K+. High K+ solution was prepared
by equimolar substitutions of 45 mm KCl for NMG-Cl.
Peptide release
Rat neurohypophyses (see Electrophysiological recordings) were
homogenized as described previously (Dayanithi et al. 1988). The
homogenate was centrifuged at 2400 g for 6 min. The resulting
pellet contains highly purified nerve terminals. The nerve endings
were equally loaded onto four filters (0 45 #um Acro disc, Gelman
Sci., Ann Arbor, MI, USA) and perfused at 37 °C with normal LS.
Control experiments were always run in parallel with the toxin
experiments. Four minute fractions of perfusate were collected and
the evoked release was triggered by an 8 min duration pulse of a
depolarizing concentration (50 mM) of K+ (indicated by the arrows
in Figs 6 and 7). The results are given as arginine vasopressin
(AVP) or oxytocin (OT) release per fraction using specific radio-
immunoassays (Cazalis et al. 1987; see also below). The medium
before and after the depolarizing period contained (mM): 40 NaCl, 5
KHCO3, 100 NMG-C1, 1 MgCl2, 2 CaCl2, 10 glucose, 10 Tris-Hepes
and 0-02% BSA; pH 7-25. Depolarization medium contained
50 mM K+, in which NMG-Cl was reduced to maintain the
osmolarity (300-310 mosmol 1-).
The released AVP and OT were assayed by radioimmunoassays
using specific antibodies (kindly supplied by Dr R. John Bicknell,
AFRC Institute of Animal Physiology, Babraham, Cambridge,
UK). AVP and OT antisera were raised in sheep, the latter by
Dr Sheldric and Dr Flint. The final dilutions of antibodies used here
were 1: 120 000 for AVP and 1: 90 000 for OT. The cross-reactivity
of the OT antiserum with AVP was 0 015%, whereas that of the
AVP antiserum with OT was 0'001 %. The limits of sensitivity of
the assays were 0 5 pg (AVP) and 1 pg (OT). The inter- and intra-
assay coefficients of variation were 5-7% for AVP and 7-9% for
OT. AVP and OT standards were purchased from Calbiochem-
Novabiochem Co. (La Jolla, CA, USA). 1251-labelled AVP and OT
were purchased from Amersham, France.
All results are given as means + standard error of the mean (S.E.M.)
and significance of differences was analysed using SigmaStat
(Jandel Scientific, San Rafael, CA, USA) by using Student's or
Tukey's t tests.
RESULTS
Binding
In order to determine the types and pharmacology of
neurohypophysial Ca2+ channels, saturation radioligand
binding experiments were first conducted (Kristipati et al.
Preliminary experiments on crude membranes prepared
from rat neurohypophyses showed primarily low-affinity
non-saturable binding of the radioiodinated conopeptides
(data not shown). Subsequent binding experiments used
purified plasma membranes, and, because of the larger
amounts of material required, bovine neurohypophyses
were used. Previous studies (Kristipati et al. 1994) have
shown that Kd values for binding of radioiodinated MVIIA
and MVIIC are, within experimental error, identical on
membranes prepared from rat and cow brain.
With the isolated plasma membranes prepared from bovine
neurohypophyses, '25I-labelled synthetic MVIIA (SNX- 111,
a specific N-type channel blocker) was found to have a
single class of high-affinity binding sites (Fig. lAa;
Kd, 1-6 + 0X4 pM, n = 3 independent experiments, Bmax
(maximal number of binding sites), 1 1 + 0 3 pmol (mg
protein)-'). These results are consistent with previous data
obtained for the rat neurohypophysis using GVIA
(Dayanithi et al. 1988), a conopeptide of different binding
kinetics from but similar specificity to MVIIA (Kristipati et
al. 1994; Olivera et al. 1994). The Kd obtained here for
MVIIA is similar to that (3-2 + 0'7 pM) obtained with
central synaptosomes from the rat (Kristipati et at. 1994;
Olivera et al. 1994), while the Bm&x value obtained with the
peptidergic nerve terminals is slightly higher than that
obtained (0 54 pmol mg-') with CNS synaptosomes
(Kristipati et al. 1994; Olivera et al. 1994).
Displacement of radiolabelled MVIIA by unlabelled
MVIIA or MVIIC (Fig. lBa) gave Ki values of 0 47 + 0 4
(n= 3) and 30 + 7 pM (n = 3), respectively. In comparison,
the corresponding values for central synaptosomes are
0 39 + 0-02 (n = 3) and 12-6 pM (n = 1), respectively. It is
concluded that there is a single high-affinity binding site for
the N-type Ca2+ channel-selective conotoxins on the isolated
neurohypophysial plasma membranes, and that this site is
similar or identical to that on CNS synaptic membranes.
In contrast, saturation binding experiments with the less
selective synthetic toxin MVIIC (SNX-230) showed evidence
for multiple binding sites (Fig. lAb). The binding isotherm
was fitted to logistic equations with one to three binding
sites, and in all cases the Kd value obtained for the highest
affinity binding site was within the range obtained with
membranes prepared from central synaptosomes (5-10 pM,
data reflect three independent experiments). The Bmax
values estimated for the highest affinity binding site were
also within the range obtained with central synaptosomes
(from 1 to 1-5 pmol mg protein' for the highest affinity
site). However, the data are different from those obtained
from CNS synaptic membranes in that the latter show only
a single high-affinity site for MVIIC, which is attributed to a
P/Q class of Ca2+ channel (Kristipati et at. 1994; Olivera et
al. 1994).
Displacement of radioiodinated MVIIC from the neuro-
hypophysial membranes (Fig. lBb) showed that, unlike CNS
synaptic membranes (Hillyard et al. 1992; Ramachandran et
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al. 1993; Kristipati et al. 1994; Gaur et al. 1994; Olivera et
al. 1994), multiple binding components are observed with
displacements by both MVIIA and MVIIC. However, with
both displacing ligands, the values of IC50 for the major
component are indistinguishable from those obtained with
CNS synaptosomes at comparable radioligand concentrations
(30-100 nm with MVIIA, 10-50 pM with MVIIC, values
bound the data from three experiments). In CNS synapto-
somes this displacement is thought to reflect occupancy by
MVIIC of the P/Q class of Ca2+ channels (Kristipati et al.
1994; Olivera et al. 1994). Thus this additional high-affinity
MVIIC site on the posterior pituitary membranes led us to
test whether a functional P- or Q-type Ca2+ channel also
existed on these nerve terminals.
Ca2+ channel currents
The use of the DHP Ca2P channel antagonist nicardipine (at
2-5 uM) selectively inhibited the long-lasting component of
the Ba2+ current (Fig. 2) in these isolated neurohypophysial
terminals. This confirmed experiments at the single-channel
level, indicating selective blockade of the L-type Ca2+
channel (Lemos & Nowycky, 1989; Wang et al. 1993a). As
can be seen in Fig. 2A and B, this block reached plateau
values within 3 min, and remained steady for up to 1 h
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(data not shown). Further addition of 800 nM GVIA
(SNX- 124) or MVIIA (SNX-1 11) led to rapid inhibition of
a large proportion (39-8 + 5%, n = 8) of the isolated
transient component of the Ba2+ current (Fig. 2A and B).
This concentration had been previously shown to maximally
block the transient component (Wang et al. 1992), which had
an IC50 of 50 nm for GVIA. However, in agreement with
previous results, not all of the transient component could be
blocked by this or even higher (3-4 /M) concentrations of
this toxin (Fig. 2C).
In a majority (57%; see group 1 of Table 1) of neuro-
hypophysial terminals, subsequent addition of low (36 nM)
concentrations of MVIIC inhibited (by 31 4 + 9%, n = 3)
this resistant component and higher (150 nM) concentrations
almost completely abolished it (Fig. 2A). The IC50 using
MVIIC for the resistant component was 40-8 nM (Fig. 3A).
Higher concentrations (1 /SM) could also inhibit the N-type
Ba2+ current (data not shown).
In order to test whether the resistant component could be a
P/Q-type channel, the same protocol was repeated (Fig. 2B),
but instead of MVIIC the funnel-web spider toxin AgaIVA
(Mintz et al. 1992) was subsequently added. Even with long-
term incubations, concentrations (< 30 nM) at which this
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Figure 1. Saturation and displacement binding of synthetic w-conopeptides to the plasma
membranes of the neurohypophysial terminals
A, saturation experiments for MVIIA (a) and MVIIC (b). The line indicates linear Scatchard relationship for
MVIIA binding. B, displacement experiments, with MVIIA (a) or with MVIIC (b), using the 125I-labelled
conopeptide. Note the different scales. Binding experiments were performed on plasma membranes
prepared from bovine neurohypophyses. Displacement data are fitted with logistic equations for 1 and 2 site
models (Kristipati et al. 1994; Olivera et al. 1994).
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Figure 2. Subpopulations of the macroscopicIme in the neurohypophysial terminals can be pharmacologically
identified by applying different Ca'+ channel blockers
IBa' elicited with 5 mm~v Ba!+ as the charge carrier, was recorded using the perforated-patch-clamp method on individual isolated
neurohypophysial nerve terminals of the rat. Ab, a series of representative (typical of group 1; see Table 1) traces of macroscopic
mBa elicited by depolarizations from -80 (holding potential, 7h) to +10 mV. The largest current was recorded under control
conditions and the others after subsequent applications of the L-type blocker nicardipine, the N-type Ca!' channel blocker
MVIIA, and the P/Q-type blocker MVIIC. Aa, time-response curve of the peak values of 'Ba with the corresponding traes in b,
shown by the different bars, indicating each maximal effect. Bb, a series of representative traces (again typical of group 1) of
macroscopic 'Ba elicited by depolarizations to +10 mV from a holding potential of -80 mV. The largest 'Ba was recorded under
control conditions and the others after subsequent applications of nicardipine, then GVIA at saturating concentrations, and, finally,
another P/Q-type Ca!+ channel blocker, AgaIVA. Ba, time-response curve of the peak values of I.. with the corresponding
traces (b), shown by the different bars, indicating each maximal effect. Cb, representative (typical of group 2; see Table 1) traces of
macroscopic I.. in the isolated rat neurohypophysial terminal that was not pharmacologically sensitive to the P/Q-type Ca!+
channel blockers AgaIVA or MVIIC. Using the same protocols as described in A and B, IBa was recorded under control conditions
and the others after subsequent applications of the L-type blocker nicardipine, the N-type CaP+ channel blocker MVIIA (in order
to ensure that all of this type of current was blocked), and the P/Q-type blockers MVIIC and AgaIVA. Unlike the results shown
in A and B, there was a residual I.. that could not be inhibited by either AgaIVA or MVIIC. Ca, time-response curve of the
peak values of I.. with the corresponding traces in b, shown by the different bars, indicating each maximal effect.
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Table 1. Relative effects of different OaW' channel blockers on neurohypophysial terminals
Channel Ica Ica [Ca2+] [Ca2+]j Release of Release of
blocker (group 1) (group 2) (group 1) (group 2) AVP OT
Per cent of total 57 43 47 53
Nic (L) 28'6 + 37 24-9 + 67 28-5 + 44 25-4 + 67 307 + 2-5 295 + 3-3
GVIA (N) 35-1 + 1-8 51P1 + 4-5 33-5 + 3-7 67-6 + 8-25 31P8 +1P8 31P5 + 5-1
MVIIC (Q) 31P4 + 2-2 7 9 + 3-2 30 0 + 5f1 -3-3 + 8-2 24-5 + 1 1 -3-5 + 8&2
None 4 9 + 1P9 16-1 + 2-5 8-0 + 1-4 10-3 + 3-7 13-0 + 1-4 35-5 + 5-1
The relative contributions of the different Ca2P channel types to macroscopic Ca2+ current (ICa),
intraterminal calcium ([Ca2+]j), vasopressin (AVP) and oxytocin (OT) release were assessed by blocking
with the appropriate concentrations of blockers known to be relatively specific for each type (L, N and Q) of
Ca2+ channel. Nicardipine (Nic; 2-5-5 /M) was used to block the L-type, 800 nM GVIA or MVIIA to block
the N-type, and 100-300 nm MVIIC to block the putative Q-type Ca2P component. The neurohypophysial
terminals tested (n = 69) were sorted into two groups depending on whether they were (group 1) or were not
(group 2) affected by low concentrations of MVIIC (or high concentrations of AgaIVA) after application of
nicardipine and MVIIA/GVIA. All data are expressed as percentages of total + S.E.M.
toxin is reported to be specific for P-type channels (Mintz et
at. 1992) had no significant effect on the resistant Ba2+
current component (10- 2 + 3 9%, n = 5, P> 0 05), but at
higher concentrations (IC50, 116-5 nM; Fig. 3B) AgaIVA
completely, but reversibly, blocked the remaining Ba2+
current (Fig. 2B). The block of the resistant Ba2+ current by
AgaIVA was much faster than that by MVIIC (Fig. 2), even
when the latter was applied at higher (> 450 nM)
concentrations. Similar inhibition was observed using FTX,
another P-channel selective toxin from the funnel-web spider
(Wang & Lemos, 1994). In some terminals, in contrast, the
resistant current was not blocked by either AgaIVA or
MVIIC (see Fig. 2C and group 2 in Table 1). For this
experiment MVIIA was used because while both GVIA and
MVIIA have similar specificities and potencies, MVIIA acts
more quickly and its action is more easily reversible.
The inhibition of the resistant Ca2+ current component, in
about half of the neurohypophysial terminals, by both low
concentrations of MVIIC and high concentrations of AgaIVA
led to the conclusion that this channel most closely resembles
the a1A Ca2+ channel subunit expressed in Xenopus oocytes
(Sather et al. 1993) and/or the Q-type channel reported in
cerebellar granule neurons (Randall & Tsien, 1995). Bio-
physical characterization of the GVIA- and DHP-resistant
component of the neurohypophysial terminal Ica also favours
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Figure 3. Dose-response curves for both MVIIC and AgaIVA inhibition of the nicardipine- and
GVIA-resistant, macroscopic IBa of neurohypophysial nerve terminals
A, dose-response curve for the effect of MVIIC on the non-L and non-N IBa in a total of eleven nerve
terminals (each concentration is presented as the mean S.E.M.). B, dose-response curve for the effect of
AgaIVA on the non-L and non-N IBa in a total of fourteen nerve terminals (means + S.E.M.). The IC50 of
each curve was obtained from fitting with the equation: I= Ima - (x/(IC5o + x))), where I is the current
amplitude at a given voltage, Imax is the maximum current and x is the concentration of the blocker.
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a Q-type Ca2+ channel classification. This component of the
current is a transient, high-voltage-activated Ba2+ current
with a rate of inactivation of 22-7 ± 2-9 ms (n = 10; see
also Fig. 2) during a step to 0 mV. Figure 4 compares the
activation and steady-state inactivation curves of the L-, N-
and Q-type components of the nerve terminal Ca2+ current.
The activation (V%, -17-1 mV) and steady-state inactivation(V4, -68-2 mV) characteristics of this neurohypophysial
MVIIC- and AgaIVA-sensitive current in this group (1) of
terminals are also most consistent with those of the Q-type
Ca2P channel. The DHP- and GVIA-resistant Ca2' channel
component of group 2 appears to have similar biophysical
properties, but it has not yet been well characterized.
Intraterminal [Ca2+]
As previous experiments had effectively shown roles for
the N-like and L-like Ca currents in the release of AVP
(Cazalis et at. 1987; Dayanithi et al. 1988), subsequent
experiments were directed towards demonstrating a role for
the Q-like current in depolarization-secretion coupling. In
order to investigate its contribution to depolarization-induced
rises in bulk [Ca2+]i, terminals were loaded with fura-2 and
perfused with 15-20 s duration pulses of 50 mm K+.
Toxin additivity experiments were performed with
concentrations of GVIA (800 nM) and MVIIC (300 nM) that
produced maximal block of the fura-2 signal for each
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peptide. Under these conditions, two separate populations
of nerve terminals were observed (Fig. 5A and B), based on
whether or not MVIIC, after GVIA, had any significant
effect on depolarization-induced rises in bulk [Ca2+]j. In
about half (53%) of the terminals tested (n = 33), MVIIC
substantially inhibited (by 34%) the GVIA-resistant increase
in [Ca2+], (Fig. 5B). Thus the two conotoxins showed
substantial additivity in their inhibitions. Interestingly, in
this group GVIA showed only a modest (33 5%) inhibition,
while in the other group of terminals (group 2), GVIA
showed a more significant (67-6%) inhibition, but, most
importantly, subsequent applications of MVIIC did not have
any statistically significant effect (Fig. 5Ab). As illustrated
in Fig. 5Aa for a single terminal, addition of 800 nM GVIA
greatly inhibited the rise in intraterminal [Ca2+] in response
to 50 mM K+. Subsequent addition of 300 nM MVIIC
(together with GVIA), however, gave no further reduction of
the rise in [Ca2+],. Note that there is no siginificant run-
down in the fura-2 response, as indicated by the almost
identical responses to the two control (no added toxins)
stimulations given initially. In Fig. 5Ba, in contrast, is a
representative group 1 neurohypophysial terminal, where
MVIIC had a significant inhibition and GVIA showed a
more modest inhibition of the rise in [Ca2+]i. The remaining
increase in [Ca2+]i was nearly eliminated by subsequent
applications of 5,UM nicardipine. In Fig. 5Ab and Bb these
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Figure 4. Voltage dependence of BaP+ currents in the rat neurohypophysial terminals
Activation (0) and steady-state inactivation (0) curves for the three pharmacologically isolated,
macroscopic Ba2+ currents are illustrated. These representative curves were obtained from isolated Ba2+
currents recorded from three different single nerve terminals. The peak Ba2+ responses were normalized to
the maximal currents (for the steady-state inactivation curve) or conductances (for the activation curve)
and plotted vs. the holding potentials or vs. the depolarizing potentials. Data for activation and steady-
state inactivation were fitted using appropriate forms of the Boltzmann equations. For activation, the
equation is G= Omax (1 + exp(( V4 - V8)/k))', whereas for steady-state inactivation, the equation is
I= Ima (1 + exp(( V. - VJ)/k)r, where G is the conductance at a given voltage, Gmax is the maximum
conductance, I is the current amplitude at a given voltage, Imax is the maximum current, V. is the voltage
step, V% is the mid-point potential and k is the slope parameter. A, in order to isolate the L-type IBa, the
terminal was pretreated with 800 nm MVIIA and 100 nM MVIIC. The fitting of the two curves for the
isolated, nicardipine-sensitive, long-lasting IBa gives V% values of -11-4 mV (k= 2-3) and -30-3 mV
(k= 12-3) for activation and inactivation, respectively. B, the isolated N-type Ba current was obtained by
applying the L-type Ca2+ blocker nicardipine (2-5 FM) and the P/Q channel blocker AgaIVA (450 nM). The
fitting of the two curves for the isolated, GVIA-sensitive (N-type) IBa gives V% values of -21-2 mV
(k = 2-6) and -68-5 mV (k = 3-2) for activation and inactivation, respectively. C, using the same protocols
as described in Fig. 2A and B, the MVIIC/AgaIVA-sensitive, transient IB. was isolated. The fitting of the
two curves for the isolated Q-type IBa gives V& values of -17-1 mV (k= 4-4) and -68-2 mV (k= 3-8) for
activation and inactivation, respectively.
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Figure 5. Sensitivity of depolarization-induced [Ca2+]i transients to Ca2+ channel blockers
Aa, representative traces, typical of group 2 (see Table 1) neurohypophysial terminals, of elevated (50 mM)
K+-induced changes in [Ca2+]1. A single nerve terminal was sequentially depolarized, with the two initial
stimulations in the absence of any channel blockers, then in the presence, as indicated, of 0-8 uM GVIA,
and, finally, together with 0 3 uM MVIIC. Each blocker was present for > 2 min prior to K+-induced
(arrows) membrane depolarizations (each for 20 s) with each treatment containing the blocker in
combination with those used in the prior K+ stimulations. Breaks in the trace omit recovery periods
(> 4 min) following K+-induced depolarization. Ab, summarized data for group 2 (53 %) of terminals tested.
The bar graph shows the percentage (%) of control [Ca!+], evoked by high (50 mM) K+ after treatment for
3-5 min with subsequent applications of 0-8 /M GVIA, plus 0 3 /M MVIIC, and plus 5/M nicardipine.
Ba, representative recording, typical of group (see Table 1) neurohypophysial terminals, of elevated
(50 mM) K+-induced changes in [Ca2+]i A single nerve terminal was sequentially stimulated, initially in the
absence of any channel blockers, then in the presence, as indicated, of 0-8 uM GVIA, 0 3 /zM MVIIC and
5/M nicardipine. Each blocker was present for > 2 min prior to K+-induced (arrows) membrane
depolarizations (each for 20 s) with each treatment containing the blocker in combination with those used in
the prior K+ stimulations. Breaks in the trace omit recovery periods (> 4 min) following K+-induced
depolarization. Bb, summarized data for group 1 (47 %) of terminals tested (n = 33). The bar graph shows
the percentage (%) of control [Ca2+], evoked by high (50 mM) K+ after treatment for 3-5 min (see Ba) with
subsequent applications of 0-8 /M GVIA, plus 0 3 /M MVIIC, and plus 5 #M nicardipine. Note S.E.M. bars
and significant effects (*) at the P < 0 05 level above each relevant bar.
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results are summarized, and in Table 1 are correlated with
the electrophysiological data.
Peptide release
In order to determine whether the Q-type Ca2+ channel
could play a role in neurosecretion, AVP and OT release
from perfused populations of isolated nerve terminals was
359
measured using peptide-specific radioimmunoassays (see
Methods, and also Cazalis et al. 1987). Figure 6A shows
that repeated stimulation with high (50 mM) K+ gave, each
time, essentially identical AVP release profiles. Utilizing
the same pharmacological protocol used to isolate the
Q-component electrophysiologically (see Fig. 2), a similar
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Figure 6. Effects of Cae' channel blockers on the release of AVP from isolated rat
neurohypophysial nerve terminals
A, AVP release stimulated by 50 mm K+ (arrows) repeatedly (Si, S2, S3 and 84) at regular time intervals.
B, using a similar experimental protocol, the nerve terminals were challenged with elevated K+ either in
the absence of channel blockers (Si) or in the presence of 5/FM nicardipine (S2), 800 nM GVIA (S3) and
300 nM AgaIVA (84), as indicated by bars. All these drugs were present for at least 20 min before, during,
and after K+ challenge. C, similarly, in order to further characterize the latter component of Ca2+-dependent
release, 100 nm MVIIC was added 20 min before and during the S4 stimulus. All data points represent the
mean + S.E.M. of 4-6 experiments.
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resistant component of Ca2+-dependent AVP release was
revealed (Fig. 6Band C). This confirmed earlier experiments
(Dayanithi et al. 1988), which showed that even saturating
concentrations of DHP and GVIA when added together
could not abolish all of Ca2+-dependent peptide release
(Wang et al. 1993b). More importantly, when either high
(300 nM) concentrations of AgaIVA (Fig. 6B) or low
(100 nM) concentrations of MVIIC (SNX-230; Fig. 6C) were
subsequently added to the isolated terminals, this resistant
component of AVP release was essentially abolished
(P < 0 001, Student's t test). This was also true even if the
order of drugs was reversed or scrambled (data not shown).
Furthermore, stimulated release was stable during prolonged
applications of each of the Ca2P channel blockers, indicating
that steady-state effects had been established.
In contrast, complete inhibition of release was not obtained
with OT. Utilizing the same pharmacological protocol used
to isolate the Q-component electrophysiologically (see
Fig. 2) and for AVP release (Fig. 6), a similar resistant
component of Ca2+-dependent OT release was revealed
(Fig. 7). In contrast to AVP release, however, when either
low (100 nM) concentrations of MVIIC (Fig. 7B) or high
(300 nM) concentrations of AgaIVA (Fig. 7C) were
subsequently added to the isolated terminals, this resistant
component of OT release was essentially unchanged
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Figure 7. Effects of COa2 channel blockers on the release of OT from isolated rat
neurohypophysial nerve terminals
A, OT release stimulated by 50 mm K+ (arrows) repeatedly (S1, S2, S3 and S4) at regular time intervals.
B, using a similar experimental protocol, the nerve terminals were challenged with elevated K+ either in
the absence of channel blockers or in the presence of 5/uM nicardipine, 800 nm GVIA and 100 nm MVIIC,
as indicated by bars (see Fig. 6). All these blockers were present for at least 20 min before, during and after
K+ challenge. C, similarly, in order to further characterize the latter component of Ca2'-dependent release,
300 nM AgaIVA was added 20 min before and during the S4 stimulus. All data points represent the
mean + S.E.M. of 4-6 experiments.
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(P = 0 11). Furthermore, the lack of effects of the Q-channel
blockers on OT release was significantly (P c 0f001; Tukey's
test) diffierent from their effiects on AVP release (Table 1).
DISCUSSION
By using purified plasma membranes from neurohypophyses,
we were able to obtain saturable high-affinity binding of
radiolabelled synthetic MVIIA, and complex (i.e. > two
sites) but high-affinity binding of radiolabelled synthethic
MVIIC (Fig. 1). The high-affinity binding of MVIIA
behaves identically on neurohypophysial plasma membranes
and central synaptosomes and almost certainly reflects
binding to the N-type Ca2+ channel (Kristipati et at. 1994;
Olivera et al. 1994). Neurohypophysial membranes are
different from CNS synaptosomal membranes in tbat the
latter only show evidence for a single predominant binding
site for MVITC (Kristipati et al. 1994), while the former show
clear evidence for multiple binding sites (Fig. lAb and Bb).
Despite this, the majority of high-affinity MVIIC binding
on the neurohypophysial terminals was indistinguishable
from that on CNS synaptosomes in being displaced with
high affinity by MVIIC and with low affinity by MVIIA or
GVIA. Since dihydropyridine-sensitive Ca2+ channels are
thought to be absent from CNS synaptosomes, this binding
should represent the P/Q-type of Ca2+ channel (Kristipati
et at. 1994; Olivera et al. 1994). In contrast to CNS
synaptosomes, which contain a high abundance of P/Q-type
Ca2+ channels, the neurohypophysial terminals apparently
contain nearly equal amounts of N- and P/Q-type Ca2+
channels, not to mention DHP-binding sites (Dayanithi
et al. 1988) corresponding to the L-type Ca2+ channel. The
complexity of MVIIC binding on neurohypophysial
membranes probably reflects these differences. Furthermore,
because of species diffierences between rat and cow, as well
as the existence of nerve endings of varying diameters, the
relative proportions of N- and P/Q-type channels may be
different between the binding and the functional studies.
There appear to be four pharmacologically distinct
components in terms of relative contributions to the total
Ca2+ current (ICa) intraterminal [Ca2+], and peptide release
from neurohypophysial terminals (summarized in Table 1).
All terminals exhibit an MVIIA/GVIA-sensitive component,
but the proportion of the MVIIA/GVIA-sensitive ICa
(Fig. 2) and intraterminal [Ca2+] (Fig. 5) components is
larger than its contribution to AVP/OT release (Figs 6 and
7; Table 1). In contrast, the proportions are nearly the same
for the nicardipine-sensitive component.
As stated previously, the terminals appear to fall into two
groups: those in which the MVIIA/GVIA- and DHP-
resistant component was sensitive to MVIIC (group 1) and
those that were insensitive (group 2). In group 1 (see
Table 1), of the terminals tested, the proportions of each
Ca2+ current component were approximately equal. The
MVIIC-sensitive component in this subset of terminals
accounts for almost a third of the ICaX which is quite
comparable to its e£fects on AVP, but not OT, peptide
release, but smaller than the inhibition of increases in
[Ca2+]i by MVIIC (Fig. 5B).
Group 2 terminals (see Table 1), however, did not exhibit a
significant MVIIC-sensitive ICa component after application
of nicardipine and MVIIA/GVIA. This was also true for
about half of the terminals tested for depolgization-induced
increases in [Ca2+]i (Fig. 5A). Most interestingly, OT release
showed no sensitivity to either MVIIC or AgaIVA (Fig. 7),
again in the presence of nicardipine and GVIA. At preent
we do not know which Ca2+ channel type underlies this
resistant component of OT release, but a likely candidate
would be the 'R'-type.
The inactivation rate of the MVIIC/AgaIVA-sensitive
component of the group 1 neurohypophysial terminal Ca2+
current is much faster than any reported P-type (Llin et
al. 1992), N-type (Tsien et at. 1991), or L-type (Bean, 1989)
channel and, instead, most closely resembles either the
R-type (Zhang et al. 1993), T-type (Bean, 1989; Tsien et al.
1991), or the fastest component of the alA/Q-type (Sather et
al. 1993; Randall dr; Tsien, 1995) channels. The T-type,
however, is a low-voltage-activated channel, while the
R-type is not affiected by either MVIIC or AgaIVA, thus a
Q-type clatification seems most appropriate.
The affinity diffierences between the binding and electro-
physiological studies may be due to a number of reasons,
such as diffierent divalent cation concentrations or
diffierences in channel tertiary structure caused by
biochemical procedures or by membrane potential graxlients.
Nevertheless, we find that, as reported for the expressed
class A al-subunit in oocytes (Sather et al. 1993; Stea et al.
1994), concentrations of AgaIVA in the 100-450 nM range
are necessary for effective blockade of the Q-currents in the
neurohypophysial terminals. In contrast, the P-type Ca2+
channel is sensitive to block by < 30 nM AgaIVA (Mintz et
al. 1992). Diffierential localization of the P, Q, or other type
variants of the class A Ca2+ channel may explain these
diffierences (Stea et al. 1994; Westenbroek et al. 1995). In
further support of this, the hypothalamic cell bodies of
these neurohypophysial terminals appear to express a P-,
rather than a Q-type variant Ca2+ channel (FLsher &;
Bourque, 1995).
A heterogenous localization can also explain the lack of
contribution by the Q-type Ca2+ channel to Ca2+ intra-
terminal levels measured by fura-2 (Fig. 5B) or to IBa by
perforated-patch recordings in about half of the terminaLs
tested. The [Ca2+]i data suggest that in the group 2
terminals (see Table 1), GVIA was more substantial in its
inhibition, indicating that the proportion of N-channels was
greater here than in the group 1 terminals, which exhibited
Q-channels. Since GVIA is specific for the N-type Ca2+
channel while MVIIC blocks both N and Q, it is likely that
both these channels contribute to rises in intraterminal
calcium, but that the Q-channel is not homogeneously
distributed among the nerve endings. The total block of
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AVP release by MVIIC and AgaIVA argues that the Q-type
channels can contribute substantially to AVP peptide release
(Fig. 6). Together with the lack of any significant (see
Table 1 and Fig. 7) effiect by these same blockers on DHP-
and GVIA-insensitive OT release, these results lead to the
hypothesis that these channels are preferentially localized
on AVP peptide-containing nerve terminals, and thus do not
affiect intraterminal Ca2+ levels or currents in oxytocinergic
terminals. Q-type pharmacological heterogeneity has
recently been reported in hippocampal synaptic boutons
(Reuter, 1995). Since those terminals are homogenous in
terms of the transmitter released, it cannot be ruled out
that the heterogeneity in peptidergic terminals is instead
functional, i.e. Q-type channels can be found in both vaso-
pressinergic and oxytocinergic terminals but are not always
expressed (i.e. functionally regulated) or are, perhaps, not
coupled to the release machinery in oxytocinergic terminals.
In summary, the isolated neurohypophysial terminals are
uniquely useful for studying the biochemical, biophysical,
and functional properties of Ca2+ channels at the site of
secretion. The use of ligands with different selectivities for
the L, N and P/Q type Ca2+ channels has allowed us to show
that these three types of Ca2+ channels co-exist on these
peptidergic CNS terminals, and that they contribute to
depolarization-secretion coupling. The electrophysiological
results strongly suggest that the high-affinity MVIIA/GVIA
binding site on these nerve endings corresponds to a large
proportion of the transient (originally termed NT-type)
calcium current, while the additional high-affinity binding
site that uniquely interacts with MVIIC corresponds to the
MVIIA/GVIA-resistant component of the transient Ca2+
current. Although it has been recently shown that the P- or
Q-channel can exist in nerve terminals (Westenbroek et al.
1995) where it appears to be involved in neurotransmission
(Miljanich & Ramachandran, 1995), the biophysical
properties of the P/Q-current at nerve terminals had not
previously been defined. We show here that the fast-
inactivating, or Q-form of the alA class of Ca2+ currents
exists on these peptidergic nerve terminals, where it
participates in the control of neurohormonal secretion.
Furthermore, these Q-type channels are not homogeneously
distributed in all neurohypophysial terminals. Rather they
appear to be functional in only half of the terminals, while
the L- and N-type Ca2+ channels are co-localized in all
terminals. The release results suggest that the Q-type
component plays an important role in AVP, but not OT,
neurosecretion from these CNS terminals. Thus there
appear to be three components to Ca2+-dependent AVP
release from these nerve terminals: corresponding to 'L',
'N', and, now, 'Q'-type Ca2+ channels.
In conclusion, Q-type Ca2+ channels appear to exist in at
least one type of CNS terminal and are involved in
depolarization-secretion coupling. This lends support to the
idea that Q-type channels may play a role in synaptic
transmission in other CNS synapses (Wheeler, Randall &
Tsien, 1994; Reuter, 1995). The data presented here verify
the specific identities and importance of the Ca2+ channels
actually located at nerve terminals, but point out that one
type (Q), at least, may be heterogeneously functional. This
could have widespread ramifications in terms of CNS
synaptic plasticity.
ADAMS, M. E., MYERS, R. A., IMPERIAL, J. S. & OLIVERA, B. M.
(1993). Toxityping rat brain calcium channels with co-toxins firom
spider and cone snail venoms. Biochemistry 32, 12566-12570.
BEAN, B. P. (1989). Classes of calcium channels in vertebrate cells.
Annual Review of Physiology 51, 367-384.
CAZALIS, M., DAYANITHI, G. & NORDMANN, J. J. (1987). Hormone
release firom isolated nerve endings of the rat neurohypophysis.
Journal of Physiology 390, 55-70.
DAYANITHI, G., MARTIN-MOUTOT, N., BARLIER, s. COLIN, D. A.,
KRETZ ZAEPFEL, M., CORAUD, F. & NORDMANN, J. J. (1988). The
calcium channel antagonist -conotoxin inhibits secretion firom
peptidergic nerve terminals. Biochemical and Biophysical Research
Communications 156, 255-262.
DUNLAP, K., LUEBKE, J. I. & TURNER, T. J. (1995). Exocytotic Ca
channels in mammalian central neurons. Trends in Neurosciences
18, 89-98.
ELLINOR, p. T., ZHANG, J. F., RANDALL, A. D., ZHOU, M.,
SCHWARTZ, T. L., TSIEN, R. w. & HORNE, w. A. (1993). Functional
expression of a rapidly inactivating neuronal calcium channel.
Nature 363, 455-458.
FISHER, T. E. & BOURQUE, c. w. (1995). Distinct Z-agatoxin-sensitive
calcium currents in somata and axon terminals of rat supraoptic
neurones. Journal of Physiology 489, 383-388.
Fox, A. P., NOWYCKY, M. C. & TSIEN, R. w. (1987). Kinetic and
pharmacological properties distinguishing three types of calcium
currents in chicken sensory neurones. Journal °f Physiology 394,
149-172.
GAUR, s. NEWCOMB, R., RIVARY, B., BELL, J. R., YAMASHIRO, D.,
RAMACHANDRAN, J. & MILJANICH, G. p. (1994). Calcium channel
antagonist peptides define several components Of transmitter release
in the hippocampus. Neuropharxnacology 33, 1211-1219.
GRYNKIEWICZ, G., POENIE, M & TSIEN, R Y (1 985)- A new
generation Of Ca2+ indicators with greatly improved fluorescence
properties. Journal of Biological Chemistry 260,3440-3450.
HAMILL, o. p. MARTY, A., NEHER, E., SAKMANN, B. &
SIGWORTH, F. J. (1981). Improved patch-clamp techniques fior high-
resolution current recording firom cells and cell-free membrane
patches. Pflugers Archiv 391, 85-100.
HILLYARD, D. R., MONJE, v. D., MINTZ, I. M., BEAN, B. p. NADASDI,
L., RAMACHANDRAN, J., MILJANICH, G. P., AZIMI-ZOONOOZ, A.,
MCINTOSH, J. M., CRUZ, L. J., IMPERIAL, J. S. & OLIVERA, B. hI.
(1992). A new Conus peptide ligand for mammalian presynaptic
Ca2+ channels. Neuron 9, 69-77.
KRISTIPATI, R., NADASDI, L., TARCZY-HORNOCH, K., LAU, K.,
MILJANICH, G. P., RAMACHANDRAN, J. 8D BELL, J. (1994).
Characterization of the binding of omega-conopeptides to di«erent
classes of non-L-type neuronal calcium channels. Molecular and
Cellular Neurosciences 5, 219-228.
LEMOS, J. R. & NOWYCKY, M. C. (1989). Two types of calcium
channels coexist in peptide-releasing vertebrate nerve terminals.
Neuron 2, 1419-1426.
LIM, N., NOWYCKY, M . C. & BOOKMAN, R. J. (1990). Direct
measurement of exocytosis and calcium currents in single vertebrate
nerve terminals. Nature 344, 449-451.
) by guest on May 13, 2011jp.physoc.orgDownloaded from J Physiol (
Q-type Ca21 channels in nerve terminalsJ Physiol.502.2 363
LINDAU, M., STUENKEL, E. L. & NORDMANN, J. J. (1992).
Depolarization, intracellular calcium, and exocytosis in single
vertebrate nerve endings. Biophysical Journal 61, 19-30.
LLINA'S, R., SUGIMORI, M., HILLMAN, D. E. & CHERKSEY, B. (1992).
Distribution and fiunctional significance of the P-type, voltage-
dependent Ca!' channels in the mammalian central nervous system.
Trends in Neurosciences 15, 351-355.
MILJANICH, G. P. & RAMACHANDRAN, J. (1995). Antagonists of
neuronal calcium channels: structure, function, and therapeutic
implications. Annual Review of Pharmacology and Toxicology 35,
707-734.
MINTZ, I. M., VENEMA, v. J., SWIDEREK, K. M., LEE, T. D., BEAN,
B. P. & ADAMS, M. E. (1992). P-type calcium channels blocked by
the spider toxin o-Aga-IVA. Nature 355, 827-829.
NORDMANN, J. J., STUENKEL, E. L., KRISTIPATI, R., LEMOS, J. R. 8&
NEWCOMB, R. (1994). Polypeptide calcium antagonists and stimulus
secretion coupling in the neurohypophysis. Society for Neuroscience
Abstracts 20, 629.
OLIVERA, B. M., MCINTOSH, J. M., CRUZ, L. T., LUQUE, F. A. & GREY,
W. R. (1984). Purification and sequence of a presynaptic peptide
toxin firom Conus geographus venom. Biochemistry 23, 5087-5090.
OLIVERA, B. M., MILJANICH, G. R, RAMACHANDRAN, J. 8; ADAMS,
M. E. (1994). Calcium channel diversity and neurotransmitter
release: the omega-conotoxins and omega-agatoxins. Annual Review
of Biochemistry 63, 823-867.
RAE, J., COOPER, K., GATES, P. & WATSKY, M. (1991). LOW access
resistance perfiorated patch recording using amphotericin B. Journal
of Neuroscience Methods 37, 15-26.
RAMACHANDRAN, J., NADASDI, L., GHIL, K., KRISTIPATI, R.,
TARCZY-HORNOCH, K. T., GAUR, S., SINGH, T., BELL, J. &
MILJANICH, G. P. (1993) NOVel conopeptides reveal neuronal calcium
channel diversity. In Perspectives in Medical Chemistry,
ed. TESTA, B., KYBURZ, E., FUHRER, W. & GIGER, R. P.,
pp. 375-388. VCH Publishers, New York.
RANDALL, A. & TSIEN, R. W. (1995). Pharmacological dissection Of
multiple types Of Ca!+ channel currents in rat cerebellar granule
neurons. Journal of Neuroscience 15, 2995-3012.
REINHART, P. H., CHUNG, S. & LEVITAN, I. B. (1989). A fiamily of
calcium-dependent potassium channels firom rat brain. Neuron 2,
1031-1041.
REUTER, H. (1995). Measurements of exocytosis firom single
presynaptic nerve terminals reveal heterogeneous inhibition by Ca!+
channel blockers. Neuron 14, 773-779.
SATHER, W. A., TANABE, T., ZHANG, J.-F., MORI, Y., ADAMS, M. E. &;
TSIEN, R. W. (1993). Distinctive biophysical and pharmacological
properties of class A(BI) calcium channel a, subunits. Neuron 11,
291-303.
SNUTCH, T. &r REINER, P. B. (1992). Ca+ channels: diversity of fiorm
and function. Current Opinion in Neurobiology 2, 247-253.
STEA, A., TOMLINSON, W. J., SOONG, T. W., BOURINET, E., DUBEL,
S. J., VINCENT, S. R. & SNUTCH, T. P. (1994). The localization and
fiunctional properties Of a rat brain alA calcium channel reflect
similarities to neuronal Q- and P-type channels. Proceedings of the
National Academy of Sciences of the USA 91, 10576-10580.
STUENKEL, E. L. (I1990). Effects of membrane depolarization on intra-
cellular calcium in single nerve terminals. Brain Research 529,
96-101.
TSIEN, R. W., ELLINOR, P. T. 8& HORNE, W. A. (1991). Molecular
diversity of voltage-dependent Ca!+ channels. Trends in
Pharmacological Sciences 12, 349-354.
WANG, G. & LEMOS, J. R. (1994). Effects of fiunnel web spider toxin on
Ca!' currents in neurohypophysial terminals. Brain Research 663,
215-222.
WANG, G., NEWCOMB, R., HOM, D., MEZO, G., RAMACHANDRAN, J. &
LEMOS, J. R. (1994). Polypeptide calcium antagonists reveal two
types of transient Ca!+ channels in neurohypophysial terminals.
Society for Neuroscience Abstracts 20, 629.
WANG, x. M., TiREISTMAN, S. N. & LEMOS, J. R. (1992). TWO types of
high-threshold calcium currents inhibited by co-conotoxin in nerve
terminals of rat neurohypophysis. Journal of Physiology 44,
181-199.
WANG, x. M., TREISTMAN, S. N. & LEMOS, J. R. (1993a). Single
channel recording of L- and Nt-type calcium channels in rat
neurohypophysial terminals. Journal of Neurophysiology 70,
1617-1628.
WANG, x. M., TREISTMAN, S. N., WILSON, A., NORDMANN, J. J. &
LEMOS, J. R. (1993b). Ca!+ channels and peptide release firom
neurosecretory terminals. News in Physiological Sciences 8, 64-68.
WESTENBROEK, R. E., SAKURAI, T., ELLIOTT, E. M., HELL, J. W.,
STARR, T. V. B., SNUTCH, T. P. 8; CATTERALL, W. A. (1995).
Immunohistochemical identification and subcellular distribution of
the alA subunits of brain calcium channels. Journal of Neuroscience
15, 6403-6418.
WHEELER, D. B., RANDALL, A. &; TSIEN, R. W. (I1994). Rtoles of
N-type and Q-type Ca!+ channels in supporting hippocampal
synaptic transmission. Science 264, 107-111.
ZHANG, J.-F., RANDALL, A. D., ELLINOR, P. T., HORNE, W. A.,
SATHER, W. A., TANABE, T., SCHWARTZ, T. L. &z TSIEN, R. W.
(1993). Distinctive pharmacology and kinetics of cloned neuronal
Ca!+ channels and their possible counterparts in mammalian CNS
neurons. Neuropharmacology 32, 1075-1088.
Acknowledgements
Portions of this work were supported by Neurex Corp. and we
would like to thank members of their synthetic chemistry group for
providing the synthetic peptides. We also thank G. Miljanich for
support and advice. We would also like to acknowledge support by
NSF (National Science Foundation) grant IBN 9410834 (E. L. S.)
and NIH grant NS29470 (J. R. L.).
Author's present address
J. J. Nordmann: International Committee for the Red Cross,
Geneva, CH-2300, Switzerland.
Author's email address
J. R. Lemos: Lemos@sci.wfbr.edu
Received 7 October 1996; accepted 18 April 1997.
) by guest on May 13, 2011jp.physoc.orgDownloaded from J Physiol (
